| Cat.No. | Name | Information |
|---|---|---|
| M1861 | Silmitasertib (CX-4945) | CX-4945 (Silmitasertib) is a potent small molecule protein kinase inhibitor that selectively binds to and inhibits the enzyme casein kinase II (CK2). |
| M45304 | Casein kinase 1δ-IN-6 | Casein kinase 1δ-IN-6 is a potent and selective protein kinase CK-1δ inhibitor with an IC50 of 23 nM.Neuroprotective and anti-inflammatory activity for neurodegenerative diseases. |
| M45289 | CK2 inhibitor 2 | CK2 inhibitor 2 is a potent, selective and orally active CK2 inhibitor with an IC50 value of 0.66 nM.CK2 inhibitor 2 shows high selectivity for Clk2 (IC50=32.69 nM)/CK2 and possesses good anti-proliferative and anti-tumor activity. |
| M45285 | Hematein | Hematein is an oxidized product of hematoxylin, which can be used as a dye. Hematein is also a modified casein kinase II inhibitor with an IC50 of 0.74 μM, and also inhibits Akt/PKB Ser129 phosphorylation, Wnt/TCF pathway and increases apoptosis in lung cancer cells. |
| M45280 | Casein Kinase inhibitor A51 | Casein Kinase inhibitor A51 is a potent and orally active casein kinase 1α (CK1α) inhibitor that induces apoptosis in leukemia cells and may be used in leukemia research. |
| M45279 | CGP-029482 | CGP-029482 is a potent and selective protein kinase CK2 inhibitor. |
| M29666 | SGC-CK2-1 | SGC-CK2-1 is a highly potent, ATP-competitive, and cell-active CK2 chemical probe with exclusive selectivity for both human CK2 isoforms, with IC50s of 36 and 16 nM for CK2α and CK2α′respectively in the nanoBRET assay. SGC-CK2-1 can be used for the research of neurodegenerative diseases. |
| M29519 | NCC007 | NCC007 is a dual casein kinase Iα (CKIα) and δ (CKIδ) inhibitor with IC50s of 1.8 and 3.6 μM, respectively. NCC007 can be used in research of modulating mammalian circadian rhythms. |
| M20825 | (E/Z)-GO289 | (E/Z)-GO289 potently and selectively inhibits casein kinase 2 (CK2) at an IC50 of 7 nM in vitro kinase assay. |
| M20386 | WAY-297674 | WAY-297674 is a protein kinase (CK2) inhibitor (IC50=8.6 µM). It can be used in studies related to cancer, viral infections, and glomerulonephritis. |
| M20381 | WAY-302713-A | WAY-302713-A is a selective, non-ATP-competitive CK2α inhibitor (IC50=7.0 µM; Ki=1.6 µM) for cancer-related studies. |
| M20270 | WAY-652509 | WAY-652509 is a potent casein kinase 1δ (CK1δ/CK15) inhibitor for studies related to neurodegenerative diseases such as Alzheimer's disease. |
| M20263 | WAY-647766 | WAY-647766 is a potent Casein kinase 1δ inhibitor for Alzheimer's disease related studies. |
| M20259 | WAY-643895 | WAY-643895 is a casein kinase 1δ (CK1δ) inhibitor with >5% inhibition. It can be used in studies related to neurodegenerative diseases such as Alzheimer's disease. |
| M20257 | WAY-642424 | WAY-642424 is an inhibitor of casein kinase 1δ (CK1δ/CK15) and can be used in studies related to neurodegenerative diseases such as Alzheimer's disease. |
| M20248 | WAY-637081 | WAY-637081 is a casein kinase inhibitor for use in studies related to neurodegenerative diseases. |
| M20154 | WAY-348144 | WAY-348144 is a Casein kinase 1δ inhibitor that can be used in studies related to neurodegenerative diseases such as Alzheimer's disease. |
| M13593 | Silmitasertib sodium salt | Silmitasertib sodium salt is an orally bioavailable, highly selective and potent CK2 inhibitor, with IC50 values of 1 nM against CK2α and CK2α'. |
| M10107 | Longdaysin | Longdaysin is a Casein Kinase inhibitor with IC50 values of 8.8 μM, 5.6 μM, 52 μM and 29 μM for CKIδ, CKIα, ERK2 and CDK7. |
| M10105 | PF670462 dihydrochloride | PF670462 is a potent and selective inhibitor of of CK1 delta and epsilon (CK1δ/ε). |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
